Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.69 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.69 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.69 |
| ▸ | MEN1 | O00255 | 1/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.69 |
| ▸ | ENPP2 | Q13822 | 4/20 | 0.64 |
| ▸ | LPAR1 | Q92633 | 3/20 | 0.64 |
| ▸ | LPAR5 | Q9H1C0 | 2/20 | 0.64 |
| ▸ | LPAR6 | P43657 | 1/20 | 0.64 |
| ▸ | LPAR4 | Q99677 | 1/20 | 0.64 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.64 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.64 |
| ▸ | MAPT | P10636 | 1/20 | 0.63 |
| ▸ | DGKA | P23743 | 2/20 | 0.58 |
| ▸ | USP2 | O75604 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.57 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.56 |
| ▸ | HTT | P42858 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19241181 | 1.00 | LMNA (0.69) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL25229650 | 1.00 | LMNA (0.69) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL10477783 | 1.00 | LMNA (0.69) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL23042348 | 1.00 | LMNA (0.69) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL16236223 | 0.98 | LMNA (0.66) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL15096661 | 0.97 | LMNA (0.69) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL12554333 | 0.97 | LMNA (0.69) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL12554987 | 0.97 | LMNA (0.69) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL19941706 | 0.95 | LMNA (0.71) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL6368636 | 0.94 | KDM4E (0.59) | LMNAKDM4EDUSP3MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12214080-B2 | Micronized lipids | MCAL THERAPEUTICS INC. (US) | 2025-02-04 | — | — | US | claimed |
| US-12214079-B2 | Micronized lipids | MCAL THERAPEUTICS INC. (US) | 2025-02-04 | — | — | US | claimed |
| EP-4333794-A1 | MICRONIZED LIPIDS | MCAL Therapeutics Inc. (US) | 2024-03-13 | — | — | EP | claimed |
| CN-117580560-A | Micronised lipid | MCAL治疗公司 | 2024-02-20 | — | — | CN | claimed |
| US-20220362154-A1 | MICRONIZED LIPIDS | MCAL THERAPEUTICS INC. | 2022-11-17 | — | — | US | claimed |
| US-20220362155-A1 | MICRONIZED LIPIDS | MCAL THERAPEUTICS INC. | 2022-11-17 | — | — | US | claimed |
| US-20250221933-A1 | MICRONIZED LIPIDS | MCAL THERAPEUTICS INC. | 2025-07-10 | — | — | US | disclosed |
| US-20250221934-A1 | MICRONIZED LIPIDS | MCAL THERAPEUTICS INC. | 2025-07-10 | — | — | US | disclosed |
| US-12214079-B2 | Micronized lipids | MCAL THERAPEUTICS INC. (US) | 2025-02-04 | — | — | US | disclosed |
| US-12214080-B2 | Micronized lipids | MCAL THERAPEUTICS INC. (US) | 2025-02-04 | — | — | US | disclosed |
| CN-117580560-A | Micronised lipid | MCAL治疗公司 | 2024-02-20 | — | — | CN | disclosed |
| US-20220362154-A1 | MICRONIZED LIPIDS | MCAL THERAPEUTICS INC. | 2022-11-17 | — | — | US | disclosed |
| US-20220362155-A1 | MICRONIZED LIPIDS | MCAL THERAPEUTICS INC. | 2022-11-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220362155-A1 | MICRONIZED LIPIDS | SGMS1, SGMS2, MGLL | LMNA 3981/4885KDM4E 3924/4885DUSP3 618/4885 |
| US-20250221933-A1 | MICRONIZED LIPIDS | SGMS1, SGMS2, MGLL | LMNA 3981/4885KDM4E 3924/4885DUSP3 618/4885 |
| US-20220362154-A1 | MICRONIZED LIPIDS | SGMS1, SGMS2, MGLL | LMNA 3981/4885KDM4E 3924/4885DUSP3 618/4885 |
| US-20250221934-A1 | MICRONIZED LIPIDS | SGMS1, SGMS2, MGLL | LMNA 3981/4885KDM4E 3924/4885DUSP3 618/4885 |
| US-12214079-B2 | Micronized lipids | SGMS1, SGMS2, MGLL | LMNA 3981/4885KDM4E 3924/4885DUSP3 618/4885 |
| US-12214080-B2 | Micronized lipids | SGMS1, SGMS2, MGLL | LMNA 3981/4885KDM4E 3924/4885DUSP3 618/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.